Medication info
Fiosita Tablet 100/30 Milligrams (Sitagliptin Phosphate Hydrate, Pioglitazone Hydrochloride)

Fiosita Tablet 100/30 Milligrams (Sitagliptin Phosphate Hydrate, Pioglitazone Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tabletPioglitazone Hydrochloride›33.06mg / 1 tablet
Manufacturer / importer
Samik Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
Bottle package - 30 tablets/bottle, Bottle package - 100 tablets/bottle
Approval status
Active

MFDS item code 202302344 · Approved 2023.08.07 · Insurance code 644004710

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This drug may be administered as 1 tablet once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly. Assessment of renal function is recommended before and periodically during treatment with this drug. - If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or greater No dosage adjustment based on renal function is required. - Do not administer this drug if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.

Ingredients

Manufacturer
Samik Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used along with dietary and exercise therapy to help patients with type 2 diabetes achieve better blood sugar control. The two ingredients, sitagliptin and pioglitazone, work together to enhance blood sugar control and assist patients in managing their blood sugar levels. Therefore, this medication is effectively used in the treatment of type 2 diabetes.

Dosage and Administration

Adult dosage

This drug may be administered as 1 tablet once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly. Assessment of renal function is recommended before and periodically during treatment with this drug. - If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or greater No dosage adjustment based on renal function is required. - Do not administer this drug if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.

Precautions

This medication contains sitagliptin and pioglitazone, each with specific precautions. First, sitagliptin can occasionally cause severe allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, immediate discontinuation of the medication and consultation with a doctor is necessary. Additionally, sitagliptin may cause pancreatitis, which is inflammation of the pancreas; thus, if symptoms like abdominal pain, vomiting, or loss of appetite arise, inform medical personnel immediately. Pioglitazone may worsen heart failure, so patients with heart failure or a history of heart failure should not take this medication. During treatment with this medication, patients should regularly monitor for signs of heart failure such as weight gain, swelling, or difficulty breathing, and report any symptoms to their physician promptly. Moreover, pioglitazone can increase the risk of bladder cancer, therefore, patients with current active bladder cancer or a past history of bladder cancer should not use this medication. In cases of liver dysfunction or severe renal impairment, caution is advised in using this medication, and regular assessments of liver and kidney function should be performed. Women who are pregnant or may become pregnant should avoid using this medication, and premenopausal women should take precautions against pregnancy. This medication carries a risk of hypoglycemia; therefore, patients, especially those taking it with insulin or sulfonylureas, should frequently check blood sugar levels and be aware of hypoglycemic symptoms. Additionally, if sudden joint pain or skin blisters appear during treatment, it is crucial to consult a doctor immediately. Lastly, this medication may interact with various other medications; thus, patients taking other medications should inform their healthcare provider, and dosage adjustments may be necessary depending on the medications being used.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • congestive heart failure
  • fluid retention
  • edema
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
Show 57 more
  • headache
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • rash
  • urticaria
  • cutaneous vasculitis
  • severe and disabling arthralgia
  • blistering pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • elevated low-density lipoprotein
  • hyperglycemia
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • elevated liver enzyme levels
  • acute renal failure
  • vomiting
  • severe hypoglycemia
  • increased serum creatinine
  • worsening of liver disease
  • urticaria
  • eczema
  • arthralgia
  • knee abnormalities
  • loss of arm strength
  • proteinuria
  • anxiety
  • insomnia
  • drowsiness
  • simple herpes
  • blurred vision
  • hypertension
  • heart failure
  • orthostatic hypotension
  • palpitations
  • stroke
  • sexual dysfunction
  • myocardial infarction
  • abdominal pain
  • heart failure
  • decreased vision
  • liver failure
  • macular edema
  • fracture

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air, and keep it at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

Bottle package - 30 tablets/bottle, Bottle package - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.